These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 27259831)

  • 21. High prevalence of porcine circovirus viremia in newborn piglets in five clinically normal swine breeding herds in North America.
    Shen H; Wang C; Madson DM; Opriessnig T
    Prev Vet Med; 2010 Dec; 97(3-4):228-36. PubMed ID: 20970864
    [TBL] [Abstract][Full Text] [Related]  

  • 22. PCV2d-2 is the predominant type of PCV2 DNA in pig samples collected in the U.S. during 2014-2016.
    Xiao CT; Harmon KM; Halbur PG; Opriessnig T
    Vet Microbiol; 2016 Dec; 197():72-77. PubMed ID: 27938686
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genetic variation of porcine circovirus type 2 (PCV2) and its relevance to vaccination, pathogenesis and diagnosis.
    Trible BR; Rowland RR
    Virus Res; 2012 Mar; 164(1-2):68-77. PubMed ID: 22198217
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A chimeric porcine circovirus (PCV) with the immunogenic capsid gene of the pathogenic PCV type 2 (PCV2) cloned into the genomic backbone of the nonpathogenic PCV1 induces protective immunity against PCV2 infection in pigs.
    Fenaux M; Opriessnig T; Halbur PG; Elvinger F; Meng XJ
    J Virol; 2004 Jun; 78(12):6297-303. PubMed ID: 15163723
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A chimeric virus created by DNA shuffling of the capsid genes of different subtypes of porcine circovirus type 2 (PCV2) in the backbone of the non-pathogenic PCV1 induces protective immunity against the predominant PCV2b and the emerging PCV2d in pigs.
    Matzinger SR; Opriessnig T; Xiao CT; Catanzaro N; Beach NM; Slade DE; Nitzel GP; Meng XJ
    Virology; 2016 Nov; 498():82-93. PubMed ID: 27564544
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lack of effect of piglet vaccination against Porcine circovirus type 2 (PCV2) on serum viral loads of Torque teno sus virus 2 (TTSuV2).
    Nieto D; Aramouni M; Sibila M; Fraile L; Kekarainen T; Segalés J
    Vet Microbiol; 2012 May; 157(1-2):8-12. PubMed ID: 22189433
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Porcine circovirus type 2 and porcine circovirus-associated disease.
    Gillespie J; Opriessnig T; Meng XJ; Pelzer K; Buechner-Maxwell V
    J Vet Intern Med; 2009; 23(6):1151-63. PubMed ID: 19780932
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of recently described porcine parvoviruses in archived North American samples from 1996 and association with porcine circovirus associated disease.
    Opriessnig T; Xiao CT; Gerber PF; Halbur PG
    Vet Microbiol; 2014 Sep; 173(1-2):9-16. PubMed ID: 25081955
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of vaccination against sub-clinical Porcine Circovirus type 2 infection in a high-health finishing pig herd: A randomised clinical field trial.
    Nielsen GB; Nielsen JP; Haugegaard J; Denwood MJ; Houe H
    Prev Vet Med; 2017 Jun; 141():14-21. PubMed ID: 28532989
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of sow vaccination against porcine circovirus type 2 (PCV2) on virological profiles in herds with or without PCV2 systemic disease.
    Lopez-Rodriguez A; Dewulf J; Meyns T; Del-Pozo-Sacristán R; Andreoni C; Goubier A; Chapat L; Charreyre C; Joisel F; Maes D
    Can Vet J; 2016 Jun; 57(6):619-28. PubMed ID: 27247462
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Porcine reproductive and respiratory syndrome virus infection at the time of porcine circovirus type 2 vaccination has no impact on vaccine efficacy.
    Sinha A; Shen HG; Schalk S; Beach NM; Huang YW; Halbur PG; Meng XJ; Opriessnig T
    Clin Vaccine Immunol; 2010 Dec; 17(12):1940-5. PubMed ID: 20926694
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparative efficacy of experimental inactivated and live-attenuated chimeric porcine circovirus (PCV) 1-2b vaccines derived from PCV1 and PCV2b isolates originated in China.
    Li J; Yu T; Wang X; Zhou J; Gao R; Zhang F; Gao X; Gao S; Liu X
    Virol J; 2015 Jul; 12():113. PubMed ID: 26220290
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Markedly different immune responses and virus kinetics in littermates infected with porcine circovirus type 2 or porcine parvovirus type 1.
    Opriessnig T; Gerber PF; Matzinger SR; Meng XJ; Halbur PG
    Vet Immunol Immunopathol; 2017 Sep; 191():51-59. PubMed ID: 28895867
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of vaccination of boars against porcine circovirus type 2 on ejaculate characteristics, serum antibody titers, viremia, and semen virus shedding.
    Alberti KA; Estienne MJ; Meng XJ
    J Anim Sci; 2011 May; 89(5):1581-7. PubMed ID: 21169515
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Porcine circovirus type 2 in China: an update on and insights to its prevalence and control.
    Zhai SL; Chen SN; Xu ZH; Tang MH; Wang FG; Li XJ; Sun BB; Deng SF; Hu J; Lv DH; Wen XH; Yuan J; Luo ML; Wei WK
    Virol J; 2014 May; 11():88. PubMed ID: 24885983
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Detection of natural inter- and intra-genotype recombination events revealed by cap gene analysis and decreasing prevalence of PCV2 in wild boars.
    Cadar D; Cságola A; Lorincz M; Tombácz K; Spînu M; Tuboly T
    Infect Genet Evol; 2012 Mar; 12(2):420-7. PubMed ID: 22293465
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A candidate DNA vaccine encoding a fusion protein of porcine complement C3d-P28 and ORF2 of porcine circovirus type 2 induces cross-protective immunity against PCV2b and PCV2d in pigs.
    Hou Z; Wang H; Feng Y; Li Q; Li J
    Virol J; 2019 May; 16(1):57. PubMed ID: 31046793
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of cell-mediated immune responses against porcine circovirus type 2 (PCV2) Cap and Rep proteins after vaccination with a commercial PCV2 sub-unit vaccine.
    Fort M; Sibila M; Nofrarías M; Pérez-Martín E; Olvera A; Mateu E; Segalés J
    Vet Immunol Immunopathol; 2012 Nov; 150(1-2):128-32. PubMed ID: 23010221
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy and future prospects of commercially available and experimental vaccines against porcine circovirus type 2 (PCV2).
    Beach NM; Meng XJ
    Virus Res; 2012 Mar; 164(1-2):33-42. PubMed ID: 22005075
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular detection of Porcine circovirus type 2 in swine herds of Eastern Cape Province South Africa.
    Afolabi KO; Iweriebor BC; Obi LC; Okoh AI
    BMC Microbiol; 2017 Nov; 17(1):212. PubMed ID: 29096613
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.